Related references
Note: Only part of the references are listed.Psoriasis and psoriatic arthritis induced in a patient treated with infliximab for Crohn's disease
Martin Tichy et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2012)
Frequency, Phenotype, Outcome, and Therapeutic Impact of Skin Reactions Following Initiation of Adalimumab Therapy: Experience from a Consecutive Cohort of Inflammatory Bowel Disease Patients
Daniel C. Baumgart et al.
INFLAMMATORY BOWEL DISEASES (2011)
Infliximab and adalimumab-induced psoriasis in Crohn's disease: A paradoxical side effect
Marisa Iborra et al.
JOURNAL OF CROHNS & COLITIS (2011)
Infliximab-induced Psoriasis in Children With Inflammatory Bowel Disease
Girish Hiremath et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2011)
Psoriatic Skin Lesions Induced by Certolizumab Pegol
Rhonda Q. Klein et al.
ARCHIVES OF DERMATOLOGY (2010)
Infliximab-Induced Psoriaform Rash
Jonathan Goldstein et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Severe Skin Lesions Cause Patients With Inflammatory Bowel Disease to Discontinue Anti-Tumor Necrosis Factor Therapy
Jean-Francois Rahier et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Development of diffuse psoriasis with alopecia during treatment of Crohn's disease with infliximab
F. Medkour et al.
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE (2010)
Rash induced by anti-tumor necrosis factor agents in an adolescent with Crohn's disease
Laurie S. Conklin et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
OCCURRENCE OF PUSTULAR PSORIASIS AFTER TREATMENT OF CROHN DISEASE WITH INFLIXIMAB
Crystal Pourciau et al.
PEDIATRIC DERMATOLOGY (2010)
Psoriatic Skin Lesions Induced by Tumor Necrosis Factor Antagonist Therapy: Clinical Features and Possible Immunopathogenesis
Angelique N. Collamer et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2010)
Review article: anti TNF-alpha induced psoriasis in patients with inflammatory bowel disease
G. Fiorino et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Severe Cutaneous Psoriasis After Certolizumab Pegol Treatment: Report of a Case
Filippo Mocciaro et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor α therapy: results from the British Society for Rheumatology Biologics Register
M. J. Harrison et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases
Justin M. Ko et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2009)
Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata - First 120 cases from the literature including a series of six new patients
Uwe Wollina et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2008)
Polymorphisms of the IL12B and IL23R genes are associated with psoriasis
Rajan P. Nair et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION)
J. -H. Saurat et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Maintenance therapy with certolizumab pegol for Crohn's disease
Stefan Schreiber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes
Michele Cargill et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial
Jean-Frederic Colombel et al.
GASTROENTEROLOGY (2007)
Infliximab for induction and maintenance therapy for ulcerative colitis
P Rutgeerts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Infliximab can precipitate as well as worsen palmoplantar pustulosis:: possible linkage to the expression of tumour necrosis factor-α in the normal palmar eccrine sweat duct?
G Michaëlsson et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
The clustering of other chronic inflammatory diseases in inflammatory bowel disease: A population-based study
CN Bernstein et al.
GASTROENTEROLOGY (2005)
Plasmacytoid predendritic cells initiate psoriasis through interferon-α production
FO Nestle et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Cross-regulation of TNF and IFN-α in autoimmune diseases
AK Palucka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Infliximab induction therapy for patients with severe plaque-type psoriasis: A randomized, double-blind, placebo-controlled trial
AB Gottlieb et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors
M Gilliet et al.
ARCHIVES OF DERMATOLOGY (2004)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)
Share Paper
